Nelarabine
Who holds supplier records for Nelarabine? 6 organisations hold a current record for Nelarabine: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3), France (1), Taiwan (1) and Switzerland (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Nelarabine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nelarabine
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Nelarabine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 37544 · latest filing Nov 2022
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 35049 · latest filing Aug 2020
- CHEMWERTH INCFranceActive DMF 36081 · latest filing Jul 2021
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 36305 · latest filing Oct 2021
- SCINOPHARM TAIWAN LTDTaiwanActive DMF 39030 · latest filing Nov 2023
- SYNBIAS PHARMA AGSwitzerlandActive DMF 30575 · latest filing May 2016
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Nelarabine are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- ALP PHARM BEIJING CO LTDInactive DMF 24376 · filed Nov 2010
Overview
Nelarabine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201112).
Chemical identity
- IUPAC name
- (2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- Canonical SMILES
- COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N
- InChIKey
- IXOXBSCIXZEQEQ-UHTZMRCNSA-N
- Synonyms
- 506U, 506U78, Arranon, Atriance, Attriance, GW-506U78, MAY, Nelarabina, Nelarabine, Nelzarabine, NSC-686673, NSC-755985
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nucleoside Metabolic Inhibitor
- Mechanism of action
- Nucleic Acid Synthesis Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Nelarabine?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Nelarabine: Alembic Pharmaceuticals Limited (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CHEMWERTH INC (France), MSN Laboratories Private Limited (India), SCINOPHARM TAIWAN LTD (Taiwan) and SYNBIAS PHARMA AG (Switzerland). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Nelarabine Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 37544), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 35049), CHEMWERTH INC (DMF 36081), MSN Laboratories Private Limited (DMF 36305), SCINOPHARM TAIWAN LTD (DMF 39030) and SYNBIAS PHARMA AG (DMF 30575). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Nelarabine records mean?
1 organisation has only inactive Type II DMFs for Nelarabine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Nelarabine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Nelarabine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.